<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vieira GC</submitter><funding>Cancer Research UK</funding><pagination>40053-67</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4741879</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(37)</volume><pubmed_abstract>LGR5 is a marker of normal and cancer stem cells in various tissues where it functions as a receptor for R-spondins and increases canonical Wnt signalling amplitude. Here we report that LGR5 is also highly expressed in a subset of high grade neuroblastomas. Neuroblastoma is a clinically heterogenous paediatric cancer comprising a high proportion of poor prognosis cases (~40%) which are frequently lethal. Unlike many cancers, Wnt pathway mutations are not apparent in neuroblastoma, although previous microarray analyses have implicated deregulated Wnt signalling in high-risk neuroblastoma. We demonstrate that LGR5 facilitates high Wnt signalling in neuroblastoma cell lines treated with Wnt3a and R-spondins, with SK-N-BE(2)-C, SK-N-NAS and SH-SY5Y cell-lines all displaying strong Wnt inductio</pubmed_abstract><journal>Oncotarget</journal><pubmed_title>LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.</pubmed_title><pmcid>PMC4741879</pmcid><funding_grant_id>C20791/A12743</funding_grant_id><funding_grant_id>11975</funding_grant_id><funding_grant_id>12743</funding_grant_id><pubmed_authors>Zhou L</pubmed_authors><pubmed_authors>Catchpoole D</pubmed_authors><pubmed_authors>Malik S</pubmed_authors><pubmed_authors>Park JH</pubmed_authors><pubmed_authors>Greenhough A</pubmed_authors><pubmed_authors>Szemes M</pubmed_authors><pubmed_authors>Bates DO</pubmed_authors><pubmed_authors>Gabb PD</pubmed_authors><pubmed_authors>Kaidi A</pubmed_authors><pubmed_authors>Malik K</pubmed_authors><pubmed_authors>Melegh Z</pubmed_authors><pubmed_authors>Morgan R</pubmed_authors><pubmed_authors>Vieira GC</pubmed_authors><pubmed_authors>Chockalingam S</pubmed_authors></additional><is_claimable>false</is_claimable><name>LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma.</name><description>LGR5 is a marker of normal and cancer stem cells in various tissues where it functions as a receptor for R-spondins and increases canonical Wnt signalling amplitude. Here we report that LGR5 is also highly expressed in a subset of high grade neuroblastomas. Neuroblastoma is a clinically heterogenous paediatric cancer comprising a high proportion of poor prognosis cases (~40%) which are frequently lethal. Unlike many cancers, Wnt pathway mutations are not apparent in neuroblastoma, although previous microarray analyses have implicated deregulated Wnt signalling in high-risk neuroblastoma. We demonstrate that LGR5 facilitates high Wnt signalling in neuroblastoma cell lines treated with Wnt3a and R-spondins, with SK-N-BE(2)-C, SK-N-NAS and SH-SY5Y cell-lines all displaying strong Wnt inductio</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2026-05-05T12:00:52.053Z</modification><creation>2026-04-07T21:44:05.349Z</creation></dates><accession>S-EPMC4741879</accession><cross_references><pubmed>26517508</pubmed><doi>10.18632/oncotarget.5548</doi></cross_references></HashMap>